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Introduction
Ubiquitin-dependent destruction of proteins that inhibit an up-
coming event in the cell cycle provides a mechanism to govern 
unidirectional cell cycle progression. Like in lower organisms, 
in mammalian cells, cyclin B1–Cdk1 is the principal kinase 
catalyzing entry of G2 phase cells into mitosis (Lindqvist et al., 
2009), but cyclin B1 degradation and Cdk1 inactivation drive 
mitotic exit and cytokinesis (Clute and Pines, 1999; Hagting et al., 
2002;  Wolf  et  al.,  2006;  Sullivan  et  al.,  2008).  Destruction   
of separase inhibitor securin at metaphase is essential for   
sister chromatid separation (Hagting et al., 2002; Yanagida, 
2005). In mammalian cells, synchronized loss of cyclin B1 
and securin thus coordinates cell division with nuclear division 
(Pines, 2006).
By the action of spindle checkpoint proteins (e.g., Mad1, 
Mad2, Bub1, BubR1, and Mps1), cyclin B1 and securin are   
stabilized until all chromosomes are bipolarly attached to the 
mitotic  spindle  at  metaphase  (Kops,  2008;  Sczaniecka  and 
Hardwick, 2008; Kulukian et al., 2009). The spindle checkpoint 
proteins cooperate to inhibit the function of Cdc20, a WD40   
repeat–containing protein (Yu, 2007) that binds to and acti-
vates the anaphase-promoting complex/cyclosome (APC/C).   
APC/C
Cdc20 forms a multisubunit E3 ubiquitin ligase that directs   
proteasomal destruction of cyclin B1 and securin upon release 
of the spindle checkpoint (Pines, 2006; Yu, 2007; van Leuken   
et al., 2008).
The spindle checkpoint does not preclude binding of 
Cdc20 to the APC/C (Nilsson et al., 2008; Sczaniecka and   
Hardwick, 2008; Herzog et al., 2009; Kulukian et al., 2009). By 
their destruction region (involving the RXXL destruction box   
[D box]), APC/C substrates may interact with the WD40 domains 
of Cdc20 (Ohtoshi et al., 2000; Hilioti et al., 2001; Kraft et al., 
2005; Passmore and Barford, 2005). On their turn, checkpoint 
proteins could block substrate binding to Cdc20 as shown   
in vitro, suggesting that the spindle checkpoint prevents recruit-
ment of substrates to APC/C
Cdc20 (Herzog et al., 2009). Spindle 
checkpoint proteins can also induce conformational changes in 
the APC/C itself, thus repositioning Cdc20 (Herzog et al., 2009). 
This could mean that release of the spindle checkpoint helps to 
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he ubiquitin ligase anaphase-promoting complex/
cyclosome (APC/C) is activated at prometaphase by 
mitotic phosphorylation and binding of its activator, 
Cdc20. This initiates cyclin A degradation, whereas cyclin 
B1 is stabilized by the spindle checkpoint. Upon checkpoint 
release, the RXXL destruction box (D box) was proposed 
to direct cyclin B1 to core APC/C or Cdc20. In this study, 
we report that endogenous cyclin B1–Cdk1 is recruited to 
checkpoint-inhibited, phosphorylated APC/C in prometa-
phase independently of Cdc20 or the cyclin B1 D box. 
Like cyclin A, cyclin B1 binds the APC/C by the Cdk   
cofactor  Cks  and  the  APC3  subunit.  Prior  binding  to   
APC/C
Cdc20 makes cyclin B1 a better APC/C substrate in 
metaphase, driving mitotic exit and cytokinesis. We con-
clude that in prometaphase, the phosphorylated APC/C 
can recruit both cyclin A and cyclin B1 in a Cks-dependent 
manner. This suggests that the spindle checkpoint blocks   
D box recognition of APC/C-bound cyclin B1, whereas 
distinctive complexes between the N terminus of cyclin A 
and Cdc20 evade checkpoint control.
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APC/C
Cdc20 well before recognition of the D box by Cdc20, as 
triggered  by  release  of  the  spindle  checkpoint  (Kraft  et  al., 
2005; Herzog et al., 2009). In prometaphase, cyclin B1, like   
cyclin A, is directed to phosphorylated APC/C by its Cdk and 
Cks partners, but cyclin A differs from cyclin B1 in the way its 
N-terminal destruction region binds to Cdc20 in G2 phase. This 
may facilitate competition between cyclin A and spindle check-
point proteins in mitosis. We conclude that processive mitotic 
cyclin  ubiquitination  requires  their  Cks-dependent  retention   
at the APC/C in the spindle checkpoint, a binding step that pre-
cedes D box–dependent ubiquitination.
Results
Cks proteins facilitate cyclin B1–Cdk1-
dependent APC/C phosphorylation  
and activation
We aimed to study the roles of both Cks1 and Cks2 downstream 
of cyclin B1–Cdk1. Therefore, we used a non-Cks–binding 
mutant  of  human  Cdk1,  Cdk1-P242L. We  call  this  mutant 
Cdk1–1N, as it is orthologous to budding yeast Cdc28-1N that 
has a normal G1 and S function but confers a mitotic defect 
(Surana et al., 1991). To follow how mitotic progression depends 
on the ability of Cdk1 to bind Cks, we aimed to complement 
cells depleted of endogenous Cdk1 by fluorescent Cdk1 or 
Cdk1–1N constructs.
We had found that Cdk1–EYFP, when overexpressed in 
control cells, does not localize like cyclin B1 in mitotic cells 
(Fig. 1 A and Fig. S1 A). However, this was different in cells 
from which endogenous Cdk1 was depleted, and RNAi-resistant 
Cdk1–EYFP (Cdk1*–EFYP) was used to restore expression 
(transient cotransfections in U2OS cells; Fig. 1 C). In these 
cells, fluorescent Cdk1 colocalized with cyclin B1 on centro-
somes in G2 phase, entered the nucleus in prophase, and stained 
mitotic spindle, chromosomes, and kinetochores in prometa-
phase (Fig. 1 C, Fig. S1 B, and Video 1). At metaphase, Cdk1 local-
ization became dispersed as cyclin B1 was degraded (Fig. 1 C, M). 
Cdk1 remarkably escaped protein destruction, probably by dis-
sociating from cyclin B1 at the proteasome (Nishiyama et al., 
2000; Chesnel et al., 2007). Although Cdk1-depleted cells show 
mitotic defects, restoring expression by RNAi-resistant, fluores-
cent Cdk1 completely restored normal mitotic progression (Fig. 1, 
C and E; Lindqvist et al., 2007). We conclude that fluorescently 
tagged Cdk1 is functional and that the intracellular localization 
pattern of fluorescent, RNAi-resistant Cdk1 acts as a single- 
cell readout for efficient depletion of endogenous Cdk1 by our 
shCdk1 plasmid.
Cyclin B1 binding directs Cdk1 localization (Pines and 
Hunter, 1994; Draviam et al., 2001; Bentley et al., 2007). 
  Normally, Cdk1 is present in surplus over cyclin B1 (Arooz et al., 
2000), but in cells from which endogenous Cdk1 is depleted, 
increased numbers of cyclin B1–Cdk1–EYFP complexes can be 
formed. This strongly indicates that the distinct cyclin B1–like 
localization pattern of Cdk1–*EFYP as shown in Fig. 1 C is 
also a marker for binding of Cdk1–*EYFP to cyclin B1.
To investigate the function of Cks binding to Cdk1, we 
used our Cdk1 complementation assay and followed G2 and 
functionally  activate  Cdc20.  Furthermore,  the  checkpoint   
either promotes polyubiquitination and destabilization of Cdc20 
(Nilsson et al., 2008; Ge et al., 2009) or inhibits Cdc20 polyubiq-
uitination to prevent its activation (Stegmeier et al., 2007).   
In conflict with the view that the checkpoint must be released 
before substrates can be recognized or Cdc20 can be activated is 
the long-standing observation that APC/C
Cdc20 is already active 
in prometaphase, targeting cyclin A for destruction, whereas   
cyclin B1 remains stable (Stewart et al., 1994; den Elzen and 
Pines, 2001; Geley et al., 2001; Wolthuis et al., 2008).
This paradox is not explained by inferring that cyclin A   
is an extremely efficient APC/C substrate, requiring minimal 
amounts of Cdc20 for its destruction, because partial depletion 
of Cdc20 by RNAi delays cyclin A destruction at least as well 
as cyclin B1 destruction (Wolthuis et al., 2008). The C-terminal 
dipeptide of the prometaphase APC/C
Cdc20 substrate Nek2A acts 
as a direct APC/C-binding motif (Hayes et al., 2006), suggest-
ing that prometaphase APC/C
Cdc20 substrates may be recruited 
to the APC/C independently of Cdc20 to escape checkpoint con-
trol. However, Cdc20 is a rate-limiting factor for both cyclin A 
and Nek2A destruction (Hayes et al., 2006; Wolthuis et al., 
2008; Kulukian et al., 2009). This indicates that, rather, an un-
inhibited pool of Cdc20 may specifically direct the destruction 
of prometaphase APC/C substrates.
To be degraded in prometaphase, cyclin A depends on   
the conserved Cdk cofactors called Cks (the mammalian p9 
proteins Cks1 and Cks2, orthologous to fission yeast Suc1 and 
Xenopus laevis Xe-p9, collectively referred to as Cks). Cks can 
bind phosphorylated cyclin–Cdk substrates such as the APC/C 
by its anion-binding pocket (Pines, 1996; Sudakin et al., 1997; 
Patra et al., 1999; Shteinberg and Hershko, 1999). This suggests 
that Cks functions to stabilize complexes between cyclin–Cdks 
and their phosphorylated ligands. It could be acting as a proces-
sivity factor to facilitate multiphosphorylation events by cyclin–
Cdks  that  are  retained  to  their  prephosphorylated  substrates 
(Pines, 1996). Patra and Dunphy (1998) previously showed that 
Cks-dependent phosphorylation by cyclin B1–Cdk1 is required 
to activate the Xenopus APC/C in mitotic extracts. However, it 
is also possible that Cks acts as a targeting subunit, recruiting 
cyclin A to the APC/C when the APC/C is phosphorylated in 
mitosis (Wolthuis et al., 2008).
Apart from cyclin A, cyclin B1 also binds to Cks. In this 
study, we investigated interplay between cyclin B1–Cdk1–Cks 
and the mitotic APC/C. We found that although the subcellular 
localization of cyclin B1–Cdk1 was independent of Cks, Cks 
promoted mitotic APC/C phosphorylation and activation, as 
measured  by  securin  destruction  in  cells.  Remarkably,  Cks   
also retained cyclin B1–Cdk1 to spindle checkpoint–inhibited   
APC/C
Cdc20 as a substrate, secondary to enhancing APC/C phos-
phorylation. This required APC3, but not Cdc20 or the cyclin B1   
D box, yet enhanced cyclin B1 turnover in metaphase to protect 
cells against cytokinesis failure.
We conclude that Cks plays a dual role in cyclin B1   
destruction in human cells: to activate the APC/C by promoting 
cyclin  B1–Cdk1-dependent  phosphorylation  and  to  facilitate 
binding of cyclin B1 to phosphorylated APC/C
Cdc20 to make it a 
better substrate. Our data imply that cyclin B1 is recruited to 589 The prometaphase APC/C recruits cyclin B1 by Cks • van Zon et al.
Figure 1.  Cdk1-bound Cks proteins enhance APC/C phosphorylation and mitotic progression. (A) Cdk1–EYFP shows no distinct intracellular localization. 
M denotes metaphase alignment and onset of cyclin B1 destruction in U2OS cells. (B) Complementation of Cdk1 RNAi by RNAi-resistant Cdk1*–EYFP. 
(C) Reconstitution of Cdk1 depletion by Cdk1*–EYFP reveals cyclin B1 binding (Fig. S1 B and Video 1). Cdk1 localization gets dispersed upon cyclin B1 
degradation at metaphase. (D) Complementation of Cdk1 depletion by non-Cks–binding Cdk1*–1N delays cells in mitosis. (E) Reconstituted expression 
of fluorescent wild-type Cdk1 rescues Cdk1 RNAi (Lindqvist et al., 2007); NEB to anaphase (NEB-A) is normal at 24 min (n = 8). Cdk1*–1N–EYFP-
complemented cells are delayed in mitosis, NEB to anaphase is 57 min (n = 7). (right) Graph shows that Cdk1*–1N–EYFP-complemented cells delay 
independently of the spindle checkpoint. Knockdown of BubR1 (shBubR1; Lens et al., 2003) was verified by staining imaged cells with anti-BubR1 after 
fixation (not depicted). (F) Mitotic cells arrested in the spindle checkpoint were collected. Extracts were blotted with the indicated antibodies. (G) Intensities 
of the most phosphorylated forms of APC3 (ppp) and the unphosphorylated APC3 (u) from four different experiments as in F were quantified. A detailed 
description is shown in Fig. S1 E. WCE, whole cell extract. Error bars indicate standard deviations. Markers are given in kilodaltons. Bars: (A) 5 µM;   
(C and D) 10 µM.JCB • VOLUME 190 • NUMBER 4 • 2010   590
A Cks-dependent delay in mitotic exit was not rescued by 
inactivation of the spindle checkpoint (Fig. 1 E, right). This shows 
that non-Cks–binding Cdk1 delays mitotic exit independently or 
downstream of the checkpoint. Analysis of APC3 mobility shifts 
on blots confirmed that the Cdk1–Cks connection supports maxi-
mal APC/C phosphorylation in human cells (Fig. 1, F and G; and 
Fig. S1, C and E; Wolthuis et al., 2008). Both Cdk1* and Cdk1*–1N 
were equally stable in metaphase and anaphase (Fig. S1 D). We 
conclude from these experiments that in human cells, Cks does 
not  control  cyclin  B1–Cdk1  localization  but  Cdk1-dependent 
APC/C phosphorylation and metaphase progression.
mitosis  in  fluorescent  cells.  Cdk1*–1N–EYFP  expressed  in 
Cdk1-depleted cells revealed a similar intracellular localization 
as wild-type fluorescent Cdk1, with only modest reduction of 
spindle pole staining in some cells (Fig. 1 D). A potential role 
for Cks in controlling the G2/M transition was found in Xeno-
pus (Patra and Dunphy, 1996), but as far as we could detect, 
Cdk1*–1N U2OS cells entered mitosis with normal kinetics. 
However, Cks-depleted cells delayed in mitosis, most likely in 
metaphase (Fig. 1, D and E [left]; and Fig. S1 D; Wolthuis et al., 
2008), whereas Cks binding did not affect cyclin-associated   
histone 1 kinase activity in vitro (Wolthuis et al., 2008).
Figure 2.  Cks promotes APC/C–dependent destruction of cyclin B1 and securin. (A and B) Cells were treated with siRNA pools targeting Cks1 (siCks1; 
control) or both Cks1 and Cks2 (siCks1 and 2). Total amounts of siRNA were kept equal. Cells transfected with either securin-Venus (A) or cyclin B1–Venus 
(B) and expressing similar fluorescent protein levels were followed during mitosis (see Fig. S2 A for quantified fluorescence levels and total destruction 
times). (C) Fluorescence levels plotted over time starting 3 min before NEB are shown. Data are representative of three independent experiments for each 
condition. Numbers indicate minutes. Bars, 10 µM.591 The prometaphase APC/C recruits cyclin B1 by Cks • van Zon et al.
Remarkably, in Cks-depleted cells, destruction of cyclin B1 was 
delayed as compared with securin destruction (Fig. 2, B and C 
[quantitation]; and Fig. S2 A). In up to 50% of the cells express-
ing fluorescent cyclin B1, this resulted in delayed or impaired 
cleavage furrow ingression or a full cytokinesis defect (Fig. 2 B, 
right; bottom image shows accumulation of undivided cells).   
Although this phenotype was seen in cells expressing ectopic   
cyclin B1, control cells degraded at least fivefold higher amounts 
of ectopic cyclin B1 and successfully completed cytokinesis 
(Fig. S2 A, middle). This suggested that Cks proteins do not just 
control general metaphase activity of the APC/C but, at least in 
human cells, may have an additional, specific role in cyclin B1 
destruction. This helps to protect against cytokinesis failure.
Mitotic APC/C phosphorylation was similarly impaired after 
Cks depletion (Fig. 3, A and C) as upon reconstituting Cdk1 by non-
Cks–binding Cdk1 (Fig. 1, F and G; and Fig. S1 E). Interestingly, 
partial Cks depletion by RNAi clearly reduced formation of stabi-
lized interactions between APC/C
Cdc20 and endogenous cyclin B1–
Cdk1 in mitosis (Fig. 3, A–C). Binding was reduced further when 
mitotic Cks RNAi cells were also depleted of the APC/C kinase 
Plk1, which clearly suggests that the APC/C binds cyclin B1 in a 
way that depends on APC/C phosphorylation (Fig. 3, B and C).
Cks retains cyclin B1 at the APC/C as an 
APC/C substrate
Could Cks-mediated binding of cyclin B1–Cdk1 to the APC/C 
make cyclin B1 a better substrate for the APC/C? To test this in 
Cks proteins promote metaphase  
APC/C activity, with a further role in  
cyclin B1 destruction
Cks1 and Cks2 fulfill overlapping roles in mitosis (Donovan and 
Reed, 2003; Wolthuis et al., 2008). Depletion of 75–85% of both 
Cks1 and Cks2 by RNAi (further referred to as Cks depletion) did 
not reduce protein levels of Cdc20, cyclin A, or cyclin B1 in U2OS 
cells (Wolthuis et al., 2008), which is in contrast to more severe 
effects of knocking out Cks1 and Cks2 (Martinsson-Ahlzén et al., 
2008). To investigate whether Cks depletion affected metaphase 
APC/C activity in human cells, like in Xenopus extracts (Patra and 
Dunphy, 1998), we quantified destruction of a fluorescent version 
of the APC/C
Cdc20 substrate securin (securin-Venus). Cells were 
treated either with siRNA oligos targeting Cks1 alone (as a nega-
tive control) or by a combination of siRNAs targeting Cks1 and 
Cks2. Depleting a single type of Cks had no effect on securin de-
struction or cyclin B1 destruction, starting 20 min after nuclear 
envelope breakdown (NEB; Fig. 2, A and B, siCks1; for further 
siRNA controls see Wolthuis et al., 2008). In cells depleted of both 
Cks1 and Cks2, metaphase onset was delayed, probably because 
of  cyclin A  stabilization,  but  securin  destruction  started  upon 
chromosome alignment at metaphase (Fig. 2 A, siCks1 and Cks2). 
However, the time required to destroy similar levels of fluorescent 
securin was increased nearly twofold (Fig. 2, A and C [quantita-
tion], black and white triangles; and Fig. S2 A).
Normally, degradation of cyclin B1 and securin always oc-
curs simultaneously (see Fig. 7 A, middle; Hagting et al., 2002). 
Figure 3.  Cks proteins direct cyclin B1 binding to the phosphorylated APC/C. (A) Cells were treated with siRNA pools targeting Cks1 (siCks1; control, or both   
Cks1 and Cks2; siCks1 + 2). The cells were thymidine released, blocked in nocodazole, and collected by mitotic shake off. Extracts were blotted with the indi-
cated antibodies. IPs with anti–cyclin B1 antibodies were performed and blotted to examine coprecipitation of the indicated proteins. APC3 binding in cyclin B1   
IPs correlates with the hyper-phosphorylated APC3 (APC3-PPP) present in extracts. (B) Cells were treated with siRNA pools targeting Plk1 (siPlk1), both Cks1 
and Cks2 (siCks), or Plk1, Cks1, and Cks2 (siPlk1 + siCks). Mitotic cells were collected as in A, and extracts were Western blotted and probed with anti-Cks1 
antibody. (top) A background band detected by the Cks antiserum (asterisk) is shown. Serial dilutions of control (ctrl) mitotic cells show that Cks1 knockdown is 
75% after siCks or between 50 and 75% after siPlk1 + siCks. (C) The same lysates shown in B were used for IP of cyclin B1 and blotted to examine APC/C 
and Cdc20 binding. Serial dilutions of control cyclin B1 IPs are shown as a reference. Markers are given in kilodaltons. WCE, whole cell extract.JCB • VOLUME 190 • NUMBER 4 • 2010   592
fluorescent Cdk1, which alone is dispersed in the cytoplasm 
(Fig. 1 A), is often complexed to fluorescent cyclin B1 when 
these proteins are coexpressed at the right levels (Fig. 1 and   
Fig. 4 A). Thus, by analyzing cells in which fluorescent cyclin B1 
colocalized with fluorescent Cdk1, indicative of their complex 
formation, we could address whether binding of cyclin B1 to Cks 
could make it a better APC/C
Cdc20 substrate in cells. To ensure that 
ectopic expression did not affect normal cell division, only the 
cells that showed correct onset of cyclin B1 destruction at chro-
mosome alignment, or Cdk1 mutant cells showing highly compa-
rable cyclin B1 fluorescence levels as control, were analyzed.
cells, we aimed to measure destruction of cyclin B1 molecules 
bound to non-Cks–binding Cdk1–1N. In this assay, we would be 
able to address whether fluorescent cyclin B1 would become a 
less-efficient APC/C
Cdc20 substrate simply by no longer being 
able to bind Cks. Any effect found would depend exclusively on 
a role for Cks in targeting cyclin B1 to the APC/C because en-
dogenous Cks levels, and thus APC/C phosphorylation, should 
remain unchanged by the expression of these reporters.
When we coexpressed cyan fluorescent cyclin B1 with   
yellow fluorescent Cdk1, both proteins colocalized up to meta-
phase even in the presence of endogenous Cdk1. This shows that 
Figure 4.  Cks promotes recruitment of cyclin B1 as an APC/C substrate. (A) Cells were cotransfected with cyclin B1–cerulean and either Cdk1*–EYFP or 
Cdk1*–1N–EYFP. A cell undergoing mitotic exit without cytokinesis is shown. DIC, differential interference contrast. Bar, 5 µM. (B) Reduced APC/C
Cdc20 
binding of cyclin B1–Cdk1–1N complexes in cells, whereas total APC/C phosphorylation is normal. Checkpoint-arrested mitotic cells selected for expres-
sion of indicated constructs were collected. GFP IPs (pulling down Cdk1–EYFP) on equalized extracts were blotted for coprecipitation of the indicated   
proteins. Cyclin B1–Cherry is not recognized by the anti-GFP antibodies. WCE, whole cell extract. (C) Quantitative comparison of destruction times of 
cyclin B1 bound to Cdk1 (white) or Cdk1–1N (light gray). The destruction times of the cells expressing Cdk1–1N, which failed cytokinesis, are presented 
in the dark gray box. The plots contain data from three independent experiments (see Fig. S2 B for destruction curve). Markers are given in kilodaltons.593 The prometaphase APC/C recruits cyclin B1 by Cks • van Zon et al.
spindle checkpoint and before onset of cyclin B1 destruction. This 
shows that cyclin A destruction cannot escape spindle check-
point control simply because it is directed to the APC/C by Cks. 
Which differences in the way cyclin A and cyclin B1 bind APC/C 
or Cdc20 may explain their different destruction patterns?
By collecting mitotic cells in the presence of the prote-
asome inhibitor MG132, we found that binding of cyclin B1 to 
Cdc20 and phosphorylated APC/C was unaffected by the pres-
ence of stabilized cyclin A (Fig. 5 D), indicating that Cdc20 
levels  are  sufficiently  high  to  bind  both  cyclins  effectively. 
However, we found a remarkably different timing of complex 
formation: a significant fraction of cyclin A interacted with 
Cdc20 in G2 phase, when cyclin B1 bound little or no Cdc20 
(Fig.  S3  D,  compare  input  with  IP; Wolthuis  et  al.,  2008).   
Importantly, these cyclin A–Cdc20 complexes did not bind to 
the APC/C (Wolthuis et al., 2008). To compare how cyclin A 
and cyclin B1 may differ in the way they bind to Cdc20, we   
expressed GFP-tagged versions of cyclin B1, cyclin A, or an   
N-terminal cyclin A deletion mutant, arrested transfected cells 
in mitosis by proteasome inhibition, and determined Cdc20 
binding to GFP IPs. Fig. 5 E shows that cyclin A binds much 
more efficiently to Cdc20 as compared with cyclin B1. Impor-
tantly, this difference relates to a feature within the N terminus 
of cyclin A that is also required for the spindle checkpoint–
  independent destruction of cyclin A (den Elzen and Pines, 2001; 
Geley et al., 2001).
How could this variation explain the different times at 
which cyclin A and cyclin B1 are degraded? Cyclin A binds   
directly to Cdc20 by its N terminus (Ohtoshi et al., 2000) even 
without binding to the APC/C (Wolthuis et al., 2008). This sug-
gests a model in which Cdc20 that is bound to cyclin A es-
capes inhibition by spindle checkpoint proteins. Recruitment of   
cyclin A–Cdc20 complexes to the APC/C would depend on Cks 
and APC/C phosphorylation, which occurs at the same time as   
cyclin A destruction starts in prometaphase. In a comparison of 
cyclin A and cyclin B1 IPs that were normalized for the amount 
of Cdc20 coimmunoprecipitated, the amount of Mad2 that was 
detected in cyclin A IPs was indeed much lower as compared 
with the amount of Mad2 detected in cyclin B1 IPs (Fig. 5 F). 
We  suggest  from  these  experiments  that  cyclin A  can  bind 
Cdc20 in a way that prevents efficient inhibition of Cdc20 by 
the checkpoint.
Altogether, we propose that Cks binding does not influ-
ence responsiveness to the checkpoint but only the ability of 
mitotic cyclins to bind the APC/C. This is in agreement with 
our results that recruitment of cyclin B1 to the phosphory-
lated APC/C depends on Cks and is not blocked by the spin-
dle checkpoint.
Complexes between cyclin B1 and  
APC/C
Cdc20 depend on APC3, not Cdc20
Our model predicts that, in contrast to cyclin A, cyclin B1 
does not bind directly to Cdc20, or much less efficiently. De-
tection of Cdc20 in cyclin B1 IPs would thus predominantly 
reflect binding of cyclin B1 to mitotic APC/C
Cdc20 complexes. 
Because we found that binding of cyclin B1 to the APC/C   
depends on Cks and Cks can bind to phosphorylated APC/C   
Interestingly, metaphase degradation of ectopic, fluores-
cent cyclin B1 bound to fluorescent Cdk1–1N was again signifi-
cantly delayed as compared with normal fluorescent Cdk1 
control (Fig. 4 C and Fig. S2 B). Cytokinesis also failed in 50% 
of these cells (Fig. 4, A and C). Crucially, total mitotic APC/C 
phosphorylation was now unchanged, but cyclin B1–Cdk1–1N 
complexes still failed to bind phosphorylated APC/C (Fig. 4 B). 
A model emerges from these findings in which cyclin B1–Cdk1 
needs to bind Cks to stay bound to or to flux onto phosphory-
lated APC/C  in  prometaphase. This  would  direct  efficient 
processing of cyclin B1 as an APC/C substrate in metaphase, 
control mitotic exit, and safeguard cytokinesis.
Complex formation between cyclin B1 and 
phosphorylated APC/C
Cdc20 in mitosis
To study when endogenous cyclin B1 binds to the APC/C and 
Cdc20, we analyzed their cell cycle–dependent interactions. 
Cyclin B1 immunoprecipitated from extracts of mitotic cells, 
arrested  in  nocodazole,  and  collected  by  mitotic  shake  off   
(95% 4N; >90% positive for MPM2 as analyzed by FACS; see   
Materials and methods) was bound to APC/C
Cdc20. This interac-
tion was not found in extracts of G2 phase cells (Fig. 5, A and B;   
and Fig. S3, A and D). In contrast, we found few complexes   
between APC/C or Cdc20 and securin in G2 phase or mitosis 
(either with endogenous or ectopically expressed, tagged ver-
sions; Fig. S3, B and C).
Cyclin B1 bound exclusively to the maximally phosphory-
lated APC/C fraction (APC3-PPP; Fig. 5 A, compare APC3   
input [bottom] with APC3 captured in the cyclin B1 immuno-
precipitation [IP; top]). Furthermore, the APC/C retained in 
cyclin B1 IPs (kept in mitosis by proteasome inhibition after 
inactivation of the spindle checkpoint) was functionally active 
in vitro (Fig. 5 C) in a way dependent on ATP, E1, and APC/C-
specific E2 enzyme (Fig. S3, E–G; and unpublished data).   
Mitosis-specific interactions between APC/C
Cdc20 and cyclin B1 
were further found in APC2, APC3, APC4, APC6, Cdc20,   
cyclin B1, and Cdk1 IPs (Fig. S3 D; and unpublished data). We 
estimated that >25% of endogenous cyclin B1 was bound to 
the mitotic APC/C in nocodazole-arrested cells (see Fig. 8 B 
and Materials and methods). Similar complexes were found in 
extracts of cells collected by mitotic shake off 12 h after thymi-
dine release in the absence of any spindle drugs (Fig. S3 A), in 
mitotic cells arrested by nocodazole or taxol (Fig. 5 D and not 
depicted), or in cells released from the spindle checkpoint   
but kept in mitosis by proteasome inhibition (Fig. 5 D, NR, 
MG132). In conclusion, a significant fraction of endogenous 
cyclin B1 is recruited to proper APC/C and Cdc20 in prometa-
phase, regardless of the cyclin B1–stabilizing effect of the   
mitotic spindle checkpoint.
Cyclin A and cyclin B1 bind to different 
pools of Cdc20
Our  previous  data  indicated  a  key  role  for  Cks  in  directing   
cyclin A–Cdk complexes to the APC/C to promote cyclin A de-
struction, which evades inhibition by the spindle checkpoint 
(Wolthuis et al., 2008). In this study, we find that Cks recruits   
cyclin B1 to the phosphorylated APC/C, irrespective of the   JCB • VOLUME 190 • NUMBER 4 • 2010   594
Figure 5.  Binding of phosphorylated APC/C
Cdc20 to cyclin B1 starts in mitosis. (A) Cyclin B1 IPs from synchronized G2 phase and nocodazole-
arrested mitotic cells (mitosis) are shown. See Materials and methods for synchronization details. IPs were analyzed for coprecipitating proteins 
by Western blotting probed for anti-APC3 (top; showing only phosphorylated APC3) or anti–cyclin B1 (middle). (bottom) The presence of unphos-
phorylated (lane 1) and phosphorylated (lane 2) APC3 in whole cell extracts (WCE) used for the IPs (10% of input) is shown. (B) APC/C IPs using 
anti-APC6 antibodies on extracts of G2 phase cells and mitotic cells. (C) Cyclin B1 IPs on extracts from G2 or mitotic cells were used in in vitro 
ubiquitination assays. Mitotic cells arrested in nocodazole were released but kept in mitosis by the proteasome inhibitor MG132 (NR, MG132). 
Control, GFP IPs. Purified E1 enzyme, the APC/C-specific E2 enzyme UbcH10, ATP, and HA-ubiquitin (HA-Ub) were added to start the reactions. 
HA-ubiquitin–conjugated reaction products were probed with anti-HA antibody (for further controls see Fig. S3). Asterisks indicate an aspecific back-
ground band in the control GFP IPs. (D) Comparison of mitotic cells arrested in the spindle checkpoint (Noco), released from the spindle checkpoint   
arrest but kept in mitosis by MG132, or allowed to enter mitosis in the presence of MG132; the latter contain high cyclin A levels (top). Cyclin B1 
IPs are shown; negative control, securin (Sec) IP. Western blots were analyzed for coprecipitating proteins with the indicated antibodies. (top) 
Phosphorylated forms of APC3 in cyclin B1 IPs are shown. (E) Cells were transfected and selected for expression of the indicated cyclin–GFP fusion 
proteins. Mitotic cells that had entered mitosis in the presence of the proteasome inhibitor MG132 were collected by shake off. GFP IPs were probed 
for coprecipitation of Cdc20. (F) Cells were synchronized in G2 and mitosis as indicated. Anti–cyclin A IPs, anti–cyclin B1 IPs, and mitotic extracts 
were blotted for APC3, Cdc20, and Mad2. Comparable polyclonal antibodies were used detecting the N-terminal 430 amino acids of the respec-
tive cyclins. Markers are given in kilodaltons.595 The prometaphase APC/C recruits cyclin B1 by Cks • van Zon et al.
Deletion of the N-terminal destruction region or the D box 
renders cyclin B1 almost completely stable and blocks cells 
in mitosis, whereas coexpressed fluorescent cyclin B1 is de-
graded because these cells arrest downstream of the spindle 
in vitro, we tested whether the heavily phosphorylated APC   
subunit APC3 (Cdc27) could be involved in recruiting cyclin B1 
to the APC/C. Therefore, we depleted APC3 to <5% of its   
endogenous levels, leading to a robust mitotic arrest (Fig. S4, 
A and B). Cells that arrested in mitosis by APC3 depletion, 
purified by mitotic shake off, expressed high levels of cyclin A 
and cyclin B1, whereas securin was stabilized partially (Fig. 6 A 
and Fig. S5 A).
First, we analyzed why securin was stabilized only partially 
in APC3-depleted  cells.  In  yeast,  overexpression  of  the  Cdk   
inhibitor Sic1 induces mitotic exit independently of the APC3 
subunit (Thornton and Toczyski, 2003). In this study, we added 
the Cdk inhibitor roscovitine to mitotic cells, either arrested by 
spindle drugs or by depletion of either APC3 or APC2, to test first 
whether cyclin B1 stabilization depended on the mitotic arrest. 
These cells initiated cleavage furrow formation and exited mito-
sis (Fig. S4, C and D). After inducing mitotic exit in cells arrested 
by APC3 depletion, cyclin B1 remained largely stable, whereas 
securin was partially degraded (Fig. 6 A; and Fig. S5, B and C). 
However, securin was more stable after treatment of these cells 
with proteasome inhibitor MG132 (Fig. S5 B) or after depletion 
of APC2,  a  cullin-like  subunit  essential  for APC/C  ubiquitin   
ligase activity (Fig. 6 A and Fig. S5 C). This suggests that the 
APC/C can partially process securin in the absence of APC3.   
In contrast, cyclin B1 was equally stabilized after inducing mitotic 
exit in cells depleted of APC3 or APC2 (Fig. 6 A and Fig. S5 C). 
Specific securin loss in APC3-depleted mitotic cells may depend 
on residual APC/C activity, processing securin more effectively 
as compared with cyclin B1, which is in line with securin being a 
better APC/C substrate in vitro (Rape et al., 2006). Alternatively, 
destruction of mitotic cyclins depends more critically on APC3 
than destruction of securin does, like in yeast (Thornton and   
Toczyski, 2003). Regardless of the mechanism of securin loss,   
we conclude that APC3 is critical for cyclin B1 destruction inde-
pendently of the mitotic arrest.
Next, we investigated the role of APC3 in complex forma-
tion  between  cyclin  B1  and APC/C
Cdc20.  In  cells  depleted  of   
90–95% APC3, Cdc20-binding APC/C complexes remained, as   
in budding yeast and in agreement with the distinct positions   
of APC3 and Cdc20 in the modeled APC/C structure (Fig. S5,   
E and F; Herzog et al., 2009). However, in the absence of APC3, the 
mitotic APC/C no longer bound cyclin B1 (Fig. 6 B and Fig. S5 D). 
Depletion of APC2 did not abrogate binding of cyclin B1 to 
the remaining APC/C
Cdc20, indicating that complex formation be-
tween cyclin B1 and APC/C
Cdc20 requires APC3 but not APC2 or 
APC/C activity (Fig. 6 B, right, compare lane 3 with lane 4). Inter-
estingly, however, the mitotic APC/C bound normally to cyclin B1 
after Cdc20 was completely depleted from cells (Fig. 6 C, note 
that the slightly reduced APC3 signal in lane 4 correlates with 
lower input of cyclin B1 in the IP). Altogether, our findings sug-
gest that cyclin B1 recruitment to APC/C
Cdc20 depends on phos-
phorylated APC3, whereas Cdc20 is not involved in this step.
APC/C
Cdc20 binding to cyclin B1 correlates 
with a substrate retention step
How does Cks-dependent binding of cyclin B1–Cdk1 to the 
APC/C contribute to D box–dependent cyclin B1 destruction? 
Figure  6.  Retention and destruction of cyclin B1 critically depends on 
APC3. (A) Cells were arrested in mitosis by nocodazole after treatment 
with control siRNA (lanes 1 and 2) or arrested by treatment of siRNA pools 
targeting APC3 (lanes 3 and 4) or APC2 (lanes 5 and 6). 50% of these 
mitotic cells were released out of mitosis by the Cdk1 inhibitor roscovitine 
(Rosco; lanes 2, 4, and 6). Extracts were blotted and probed with anti-
bodies against the indicated proteins. (B) IPs with anti–cyclin B1 antibodies 
on extracts of mitotic cells arrested in the spindle checkpoint (nocodazole) 
by allowing the cells to enter mitosis in the presence of MG132 or by 
treatment of siRNA pools targeting APC3 or APC2. Extracts and IPs were 
probed with antibodies against the indicated proteins. (C) IPs with cyclin B1 
antibodies on extracts of mitotic cells arrested by the spindle checkpoint 
and treated with control siRNA or an siRNA pool targeting Cdc20. IPs 
were blotted and probed with antibodies against the indicated proteins. 
Identical results were obtained by using shRNA to target APC3 (Fig. S5). 
Markers are given in kilodaltons. WCE, whole cell extract.JCB • VOLUME 190 • NUMBER 4 • 2010   596
The N terminus of cyclin B1, containing the D box, re-
sponds to the spindle checkpoint and starts to be degraded at 
metaphase but does not bind Cdk or Cks (Stewart et al., 1994; 
Clute and Pines, 1999). However, the N terminus of cyclin B1, 
overexpressed in mitotic cells, failed to bind detectably to the 
APC/C (Fig. 7 D). APC/C binding was also not found when 
cells were released from the mitotic checkpoint and kept in mi-
tosis by proteasome inhibition (Fig. 7 E, cycB1-N (1X)-GFP), 
showing that the interaction between the cyclin B1 D box re-
gion and phospho-APC/C is of low affinity. Indeed, in extracts 
of postcheckpoint-arrested mitotic cells, we found that it required 
a sixfold repeat of the cyclin B1 N-terminal region to detect   
checkpoint (Fig. 7 A, left). This confirms that the D box is   
essential for cyclin B1 destruction and cytokinesis. However, a 
cyclin B1 mutant with a normal N terminus but defective in 
Cdk1–Cks binding (cyclin B1–R202A–Venus) also showed an 
impaired destruction pattern in metaphase, whereas in control 
cells, securin and cyclin B1 are degraded with similar efficien-
cies (Fig. 7 A, compare middle and right). The cyclin B1 R202A 
mutant was defective for APC/C
Cdc20 binding in mitosis (Fig. 7, 
B and C) in line with a critical role for Cks in recruiting   
cyclin B1 to APC/C
Cdc20, whereas wild-type and nondegradable 
cyclin B1 mutants, with intact Cdk–Cks binding, both bound 
comparably with APC/C
Cdc20 (Fig. 7, B and C).
Figure 7.  APC/C
Cdc20 binding to cyclin B1 cor-
relates with a substrate retention step, preced-
ing a D box–dependent ubiquitination step.  
(A) Cells were cotransfected with vectors coding 
for cyclin B1–Venus and N–cyclin B1–ECFP 
(left),  securin-cerulean  and  cyclin  B1–Venus 
(middle), or securin-cerulean and cyclin B1–
R202A–Venus  (right).  Cells  expressing  both 
proteins  were  followed  through  mitosis,  and   
fluorescence levels were plotted. Metaphase (M)   
and anaphase (A) initiation judged from dif-
ferential  interference  contrast  images  are 
shown. Graphs are representative of at least 
two  independent  experiments.  (middle  and 
right) The cells analyzed expressed cyclin B1 
or securin at low levels, allowing onset of their 
destruction  at  chromosome  alignment.  With 
wild-type constructs, sister chromatid separa-
tion and cytokinesis were normal. The other   
fluorescent constructs were expressed to similar 
levels. At least 20 cells expressing single fusion 
proteins were analyzed with similar results.   
(B and C) Wild-type and nondegradable mutants 
of cyclin B1 bind equally well to APC/C
Cdc20 
in mitosis, whereas non-Cdk–binding mutants 
of cyclin B1 do not bind. (B) Cells expressing 
Cdk-binding  mutant  cyclin  B1–R202A–Venus 
(lane 1), nondegradable N–cyclin B1–ECFP 
(lane 2), or control cyclin B1–Venus (lane 3) 
were synchronized in the spindle checkpoint 
and collected by mitotic shake off. Successful   
expression  of  the  constructs  was  validated   
by  fluorescence  microscopy  (not  depicted).   
(C) Cells expressing control cyclin B1–Venus 
(lane 1), Cdk-binding mutant cyclin B1–R202A–
Venus (lane 2), the non-Cdk–binding N-terminal   
destruction region of cyclin B1 fused to GFP 
(lane 3), or nondegradable R42A D box mu-
tants (lanes 4 and 5) were synchronized in the 
spindle  checkpoint  and  collected  by  mitotic 
shake  off.  (B  and  C)  Fusion  proteins  were 
immunoprecipitated  by  anti-GFP  antibodies, 
equally recognizing GFP or spectral variants. 
IPs were blotted and probed with antibodies 
against the indicated proteins. (D) Cells were 
treated  with  nocodazole,  and  cyclin  B1  IPs 
were  performed  on  extracts  of  the  collected 
mitotic cells (lane 1) or on extracts from an 
asynchronous  population  (lane  2).  Cells  ex-
pressing the first 97 amino acids of cyclin B1 
fused to GFP either containing an intact D box (lane 3) or an R42A-mutated D box (lane 4) were collected in mitosis. Anti-GFP antibodies were used for 
IP of the fusion proteins from extracts (lanes 3 and 4). IPs were probed for cyclin B1 and APC3. (lane 1) Binding of APC/C to endogenous cyclin B1 in 
mitosis as reference is shown. In prometaphase, binding is not detectable to the N-terminal fragments of cyclin B1. (E and F) Mitotic cells were collected by 
shake off after taxol treatment and released from the spindle checkpoint by addition of aurora B inhibitor ZM447439 but kept in mitosis by the addition of 
proteasome inhibitor MG132. After 1 h, cells were lysed and extracts used for IP of fusion proteins of GFP and the cyclin B1 N terminus (1–86), (cycB1-N 
(1X)-GFP), or tandem or sixfold repeats of the same region (cycB1-N (2X)-GFP and cycB1-N (6X)-GFP, respectively). IPs were blotted for APC3, Cdc20, or 
Cdk1 (as a negative control [ctrl]; E) or the cyclin B1 fragments (F). APC3 long exposure (APC3 le) is an overexposed blot to reveal minor APC/C binding 
to the single- or tandem-repeat cyclin B1 fragment. Markers are given in kilodaltons. WCE, whole cell extract.597 The prometaphase APC/C recruits cyclin B1 by Cks • van Zon et al.
The APC/C  from  Xenopus  mitotic  extracts  binds  an   
N-terminal, D box–containing fragment of fission yeast cyclin B 
(Yamano et al., 2004). In contrast, we did not detect binding   
of  an  ectopically  expressed  N-terminal  region  of  cyclin  B1   
and the phosphorylated APC/C in human mitotic cell extracts, 
arrested by proteasomal inhibition, unless we overexpressed a 
sixfold repeat of the D box–containing cyclin B1 N terminus. 
Although specific for an intact D box, published in vitro inter-
actions of the fission yeast cyclin B D box fragment and Xenopus 
APC/C were also reported to be of low affinity, requiring high 
concentrations of the D box region (Yamano et al., 2004; Eytan 
et al., 2006).
Figs. 2, 4, 7, and 8 show that cyclin B1 depends on Cdk1–
Cks for recruitment to the APC/C not just as a kinase but also as 
an APC/C substrate. Cks-mediated prerecruitment of cyclin B1 
becomes effective after the spindle checkpoint is satisfied in 
metaphase and supports efficient cyclin B1 destruction. The 
pool of cyclin B1–Cdk1–Cks that was not prebound to the mi-
totic APC/C in prometaphase may flux more efficiently onto the 
APC/C in metaphase. Although we show that cyclin B1–Cdk1–
Cks also plays a role in activating overall APC/C
Cdc20 activity, 
we thus demonstrate an additional, APC/C-docking function of 
Cks,  facilitating  cyclin  B1  destruction.  In  Xenopus  extracts,   
Cks was reported to predominantly direct total APC/C activity 
(Patra and Dunphy, 1998). Apart from evolutionary differences, 
possibly higher levels of APC/C activity in extracts arrested by 
nondegradable cyclin B1, differences in processivity of recom-
binant cyclin B1 as compared with endogenous cyclin B1, or 
reduced time resolution in comparison with live cell micros-
copy experiments may explain why an APC/C-docking role for 
Cks was not found in Xenopus extracts.
Proteasome-dependent protein destruction depends on a 
ubiquitin chain of significant length, so productive polyubiqui-
tination either requires sequential rounds of encounters between 
ubiquitin ligase and substrate or the ability of the ubiquitination 
enzyme to retain its substrate while ubiquitin chains are formed 
(Rape et al., 2006). Cks-dependent retention of cyclin B1 to   
the APC/C may therefore enhance processivity of cyclin B1 
ubiquitination in human cells, facilitating switch-like turnover 
in metaphase. This is physiologically relevant, as it can protect 
against a cytokinesis defect and mitotic delay (Wolf et al., 2006; 
for review see Sullivan and Morgan, 2007). Recently, we ob-
served that slow, APC/C
Cdc20-dependent loss of cyclin B1, which 
permits cells to slip out of a spindle drug–induced mitotic arrest 
(Brito and Rieder, 2006; Huang et al., 2009), may also depend 
on the substrate-capturing mechanism we describe in this study 
(unpublished data). This provides additional evidence that   
cyclin B1 binds to spindle checkpoint–inhibited APC/C
Cdc20 as 
a substrate. It also suggests further implications of our findings 
because mitotic slippage could contribute to survival of cancer 
cells after treatment with antimitotic cancer drugs (Huang and 
Mitchison, 2009). In this respect, it is also interesting that Cks1 
and Cks2 are often up-regulated in cancer (van ’t Veer et al., 
2002; Inui et al., 2003; Masuda et al., 2003; Kitajima et al., 
2004; Shapira et al., 2005; Keller et al., 2007).
Apparently,  an APC/C  targeting  mechanism  by  Cks  is 
shared between cyclin A and cyclin B1. This sheds light on the 
interactions with APC/C
Cdc20 (Fig. 7 E). Apparently, although 
upon silencing of the spindle checkpoint the D box is required 
for APC/C
Cdc20 to recognize cyclin B1 as a substrate, the D box   
region in itself is insufficient to promote stable interactions   
between cyclin B1 and mitotic APC/C
Cdc20. Therefore, we propose 
that Cdk1- and Cks-dependent binding of cyclin B1 to the   
APC/C
Cdc20 in prometaphase is required to ensure that D box– 
dependent processing of cyclin B1 is highly efficient after the 
checkpoint becomes satisfied in metaphase. In other words, we 
propose that binding to Cks by Cdk1 makes cyclin B1 a better 
APC/C substrate in cells.
Fusion proteins of the cyclin B1 N terminus and a reporter 
protein lacking the Cdk1 interaction region are widely used to 
detect metaphase APC/C activity in cells. However, we noticed 
that these reporter proteins are degraded very inefficiently, with 
>50% of fluorescence remaining at anaphase, whereas fluores-
cent versions of full-length cyclin B1 are almost completely de-
graded before anaphase. We aimed to validate that Cks is critical 
for efficient cyclin B1 destruction in metaphase independent of 
Cdk1 kinase activity. Therefore, we fused the Cks1 protein to a 
fluorescent fusion protein of the N terminus of cyclin B1 and 
tested its behavior in mitotic cells. The N terminus of cyclin B1 
does not bind to APC/C or Cdc20 (Fig. 8 A, input and total 
APC/C phosphorylation [middle] and binding [bottom]), but fu-
sion of the N terminus of cyclin B1 to Cks1 restored robust 
APC/C
Cdc20 binding in prometaphase to levels comparable with 
those found for wild-type cyclin B1 (Fig. 8 A, bottom). Further-
more, when we analyzed complex formation between APC/C
Cdc20 
in sucrose gradients of prometaphase cell extracts, we found that 
≤40% of endogenous cyclin B1 comigrated with APC/C
Cdc20, 
whereas the N-terminal cyclin B1 fragment migrated closer to 
Cdh1, the G1 phase APC/C activator that does not bind to the 
APC/C in prometaphase (Fig. 8 B, top). Interestingly, fusing 
Cks1 to the N-terminal cyclin B1 fragment shifted this pro-
tein in the gradient so it now comigrated with APC/C
Cdc20 com-
plexes and endogenous cyclin B1, whereas Cdh1, of similar 
molecular mass as the cyclin B1–N–Cks fusion, remained in the 
fractions lacking APC/C
Cdc20 (Fig. 8 B, bottom).
Finally, fusing Cks1 to the N-terminal cyclin B1 fragment 
reporter protein resulted in an intracellular localization that was 
similar to that observed for wild-type cyclin B1 in mitosis (Fig. 8 C) 
with a slight enrichment on spindle poles. This reporter was   
degraded with high efficiency in metaphase at kinetics identical 
to those of full-length wild-type cyclin B1, whereas the N-termi-
nal cyclin B1 fragment alone was degraded too slowly (Fig. 8,   
C and D; and Fig. S2 C). This shows a direct role for Cks in con-
trolling the binding of cyclin B1–Cdk1 to the APC/C, indepen-
dent of associated Cdk1 activity, to ensure efficient processing of 
cyclin B1 as an APC/C substrate in metaphase.
Discussion
In this study, we examined how cyclin B1 is recruited to the 
APC/C in mitotic cells. We found that a significant fraction of 
cyclin B1 is bound to the phosphorylated APC/C in an APC3-
dependent but D box–independent manner, even when the spin-
dle checkpoint stabilizes cyclin B1.JCB • VOLUME 190 • NUMBER 4 • 2010   598
Figure 8.  Cks enhances destruction of the N-terminal cyclin B1 fragment. (A) Cells expressing cyclin B1–Venus (lane 2), the first 86 amino acids of cyclin B1 
fused to Venus (cycB1-N-Venus; lane 3), or the same N-terminal cyclin B1 fragment fused to Cks1 and Venus (cycB1-N-Cks1-Venus; lane 4) was synchronized 
in the spindle checkpoint and mitotic cells collected by mitotic shake off. GFP IPs on equal amounts of protein precipitated the Venus fusion proteins, which 
were blotted to examine coprecipitation of the indicated proteins (bottom). (B) Spindle checkpoint–arrested mitotic cells expressing cyclin B1–N–Venus or 
cyclin B1–N–Cks–Venus were collected, and lysates were subjected to sucrose gradient centrifugation. Fractions were blotted and probed with antibodies 
against the indicated proteins. (C) U2OS cells were cotransfected with vectors encoding cyclin B1–N–cerulean (cycB1-N) and cyclin B1–N–Cks–Venus 
(cycB1-N-Cks1) and followed as they progressed through mitosis. DIC, differential interference contrast. Bar, 10 µM. (D) Venus- and cerulean-tagged   599 The prometaphase APC/C recruits cyclin B1 by Cks • van Zon et al.
(Wolthuis et al., 2008). GFP-INCENP was provided by G. Vader (The White-
head Institute for Biomedical Research, Cambridge, MA). To generate the 
cyclin B1–Cherry construct, a fragment coding cyclin B1 from cyclin B1–Venus 
was ligated in a Cherry expression vector (provided by L. Janssen, Neder-
lands Kanker Instituut, Amsterdam, Netherlands). All generated constructs 
were sequence verified.
Cell culture, transfection, selection, and synchronization
The human osteosarcoma cell line U2OS was cultured in DME in the presence 
of 8% FCS with 100 U/ml penicillin and 100 µg/ml streptomycin. The cells 
were transfected with plasmids using a standard calcium phosphate transfec-
tion protocol. For the transfections of siRNA pools, we used lipofectamine 
2000 (Invitrogen) according to manufacturer’s instructions. Cells were seeded 
in 100-mm dishes and cotransfected with 10 or 20 µg of the indicated 
pSuper-shRNAi constructs and/or 1 µg of indicated expression constructs 
and cotransfected with 1 µg pBabePuro for selection of transfected cells 
with puromycin, which was used in a 2 µg/ml end concentration during 24 h. 
Mitotic cells were collected by a gentle mitotic shake off, either arrested   
by APC3 RNAi, APC2 RNAi, or arrested with an active spindle checkpoint 
by adding nocodazole to the culture medium at a final concentration of 
250 ng/ml for 15 or 12 h after thymidine arrest (the latter also for Fig. S3 A, 
but without any drugs, leaving the mitotic cells unperturbed). To collect   
a G2 population, cells were first blocked in the G1/S transition by thymi-
dine in a final concentration of 2.5 mM for 24 h. Cells were released from 
the G1/S arrest in the presence of nocodazole. After 12 h, mitotic cells 
were removed, after which plates were thoroughly washed and remaining 
G2 cells were collected. To obtain spindle checkpoint–inactivated mitotic 
cells, cells were released from a nocodazole arrest in the presence of 5 µM 
of the proteasome inhibitor MG132. Mitotic cells that had entered mitosis 
in the presence of MG132, added 10 h after release from thymidine, were 
collected 15 h after release. Roscovitine was used to force the mitotic cells 
into G1 at a final concentration of 50 µM for 45 min. In the experiment 
shown in Fig. 7 E, cells collected by mitotic shake off after taxol treatment 
were released from spindle checkpoint arrest by addition of 1 µM of the   
aurora A inhibitor ZM447439 and kept in mitosis by simultaneous addition 
of MG132. In this case, complete checkpoint release was confirmed by 
monitoring formation of a 4N G1 population in a fraction of cells to which no 
MG132 was added. Flow cytometry was used to confirm synchrony: cells 
indicated as G2 were usually >90% 4N as detected by PI staining, and 
<10% MPM2 positive, whereas mitotic cells collected by careful mitotic 
shake off were 90–95% 4N and stained >90% positive for the mitotic marker 
MPM2. When nocodazole-arrested cells were collected by mitotic shake 
off and the drug was washed out, >90% of the cells divided within 2 h as 
detected by a near complete shift to 2N G1 cells. For flow cytometry, cells 
were fixed in ice-cold 70% ethanol and stained with mouse anti-MPM2   
antibody (United Biomedical, Inc.) and CY-5–coupled anti–mouse (Dako). 
Cell cycle distribution and MPM2 positivity of transfected cells were deter-
mined as described previously (van Vugt et al., 2004).
RNAi
pSuper vectors were used for expression of shRNAi targeting human APC3 
mRNA.  Hybridized  oligos  containing  specific  19-mer  target  sequences 
were ligated into pSuper (5-TAGCCGAGAGGTAACTCCA-3). For pSuper 
APC2, see Fig. S5 C. The pSuper vectors targeting mRNA of Cdk1 or BubR1 
were previously described (Lens et al., 2003; Lindqvist et al., 2007). An-
nealed siRNA pools to target mRNA of APC3, APC2, Cdc20, Cks1, Cks2, 
and Plk1 were purchased from Thermo Fisher Scientific as ON-TARGETplus 
SMART pools.
IPs and Western blots
Cells were lysed in ELB
+ (150 mM NaCl, 50 mM Hepes, pH 7.5, 5 mM 
EDTA, 0.3% NP-40, 10 mM -glycerophosphate, 6% glycerol, 5 mM NaF, 
1 mM Na2VO3, and protease inhibitor cocktail [Roche]). Lysates were 
cleared by centrifugation at 13,000 g for 8 min at 4°C. Protein levels were 
measured using standard Bradford analysis. For each IP, we precoupled   
2 µg antibodies to 20 µl protein G Sepharose (GE Healthcare) overnight. 
different timings of their destruction. We found that spindle 
checkpoint–independent destruction of cyclin A is preceded by 
strong binding of Cdc20 to the N-terminal destruction motif of   
A-type cyclins in G2 phase. Such binding is probably direct and 
was not found for cyclin B1 (Ohtoshi et al., 2000; Wolthuis et al., 
2008; this study). This indicates that the N terminus of cyclin A is 
unique in that it effectively competes with spindle checkpoint 
proteins  for  Cdc20  binding.  Interestingly,  Mad2  coimmuno-
precipitates with the cyclin B1–APC/C
Cdc20 complexes formed in   
mitosis, whereas cyclin A–Cdc20 complexes bind poorly to Mad2 
(Wolthuis et al., 2008; this study). In conclusion, both mitotic   
cyclins are recruited to the prometaphase APC/C
Cdc20 in a manner 
dependent on Cks, yet only cyclin A is immediately processed and 
critically  requires  Cks  for  timely  onset  of  destruction.  Cdc20 
bound to the N terminus of cyclin A evades checkpoint control 
(van Zon and Wolthuis, 2010). Cyclin B1 is also recruited to phos-
phorylated APC/C
Cdc20 in a Cks-dependent and spindle checkpoint–
independent manner, but D box–dependent processing of the 
APC/C-bound cyclin B1 awaits inactivation of the checkpoint.
As the spindle checkpoint does not prevent formation   
of stable complexes between cyclin B1, the phosphorylated 
APC/C and Cdc20, our results imply that release of the check-
point triggers APC/C
Cdc20 to bind or recognize the cyclin B1   
D box as a step secondary to cyclin B1 recruitment. APC/C com-
plexes isolated from checkpoint-arrested cells indeed inter-
acted better with recombinant N-terminal fragments of fission 
yeast cyclin B1 upon checkpoint silencing (Herzog et al., 
2009).  In  such  a  successive  substrate-binding  mechanism,   
D box binding to APC/C
Cdc20 may control correct orientation of 
the substrate toward the APC/C catalytic site, as initially sug-
gested by Burton and Solomon (2001), or direct a further, 
Cdc20-dependent  APC/C  activation  (Burton  et  al.,  2005; 
Kimata et al., 2008; Matyskiela and Morgan, 2009). However, 
exactly how recognition of the cyclin B1 D box stimulates   
cyclin B1 ubiquitination, as a result of inactivation of the mitotic 
spindle checkpoint, is still unknown.
Materials and methods
Plasmids
Vectors expressing cyclin B1–Venus or cerulean, N–cyclin B1–ECFP, and 
cyclin B1–R202A–Venus provided by J. Pines and T. Matsumoto (University 
of Cambridge, Cambridge, England, UK). Vectors expressing the N-terminal 
cyclin  B1  fragments  used  in  Fig.  7  D  were  provided  by  M.  Brandeis   
(Hebrew University of Jerusalem, Jerusalem, Israel). The other N-terminal 
cyclin B1 constructs were made by replacing full-length cyclin B1 from the 
cyclin B1–Venus or cerulean vectors with a PCR fragment coding for the 
first 86 amino acids of cyclin B1 to generate cyclin B1–N–Venus or the ce-
rulean version. Two- and sixfold repeats of this region (Fig. 7) were gener-
ated by PCR. Insertion of another PCR fragment coding for full-length Cks1 
(from Cks1-YFP; Wolthuis et al., 2008) resulted in cyclin B1–N–Cks1–Venus 
or a cerulean version. The generation of vectors expressing wild type–
  securin-Venus, Cdk1*–EYFP, and Cdk1*–1N–EYFP was described previously   
versions of cyclin B1–N or cyclin B1–N–Cks1 were cotransfected in U2OS cells. Cells either expressing cyclin B1–N or cyclin B1–N–Cks1 were followed 
during mitosis, and fluorescence levels were measured at NEB and plotted over time. For comparison, cells were also simultaneously transfected with three 
differently colored constructs, cyclin B1–N–Venus, cyclin B1–N–Cks1–cerulean, and a full-length red fluorescent cyclin B1 construct, cyclin B1–Cherry. 
Fluorescence levels of two triple-colored cells passing mitosis and performing a normal anaphase were included in the graph as a reference. Results of 
two independent experiments are shown. M, metaphase onset; A, anaphase onset. Comparable differences in destruction of the cyclin B1 reporters were 
found in >30 cells in four independent experiments. We found no significant effect of the different fluorescent tags on the destruction rates of the cyclin B1 
fragments (Fig. S2 C). Markers are given in kilodaltons. WCE, whole cell extract.
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Time-lapse fluorescence microscopy
Cells plated on 35-mm glass-bottom culture dishes (WillCo Wells) were 
transfected the following day with 0.1 µg of the indicated expression con-
structs except for 0.015 µg securin-Venus and 0.025 µg N-terminal cy-
clin B1 constructs. For shRNAi, 1 µg pSuper-Cdk1 was coexpressed with the 
indicated constructs (together with 1 µg pSuper-BubR1; Fig. 1 E, right). 
Dishes were transferred to a heated culture chamber (5% CO2 at 37°C) 
on a microscope (Axiovert 200M; Carl Zeiss, Inc.) equipped with an NA 
0.55 condenser and a 40× NA 1.3 Plan Neo differential interference 
contrast objective using a charge-coupled device camera (CoolSNAP HQ; 
Photometrics) with a GFP/DsRed or CFP/YFP dual-band pass filter set 
(Chroma Technology Corp.) to select specific fluorescence. Images were 
taken after 100-ms exposure time at 2× binning for the cyclin B1 and se-
curin experiments, and quantitated and processed using MetaMorph soft-
ware (Universal Imaging) and Excel (Microsoft).
Online supplemental material
Fig. S1 shows localization of cyclin B1 (EYFP) and Cdk1*–EYFP in cells, 
stability of the fluorescent Cdk1 constructs during mitosis, and phosphoryla-
tion of APC3 under different conditions. Fig. S2 shows destruction times   
of fluorescent cyclin B1 and securin constructs under different conditions.   
Fig. S3 shows that cyclin B1 is in complex with APC/C
Cdc20 in mitosis, which 
we do not detect for securin. Ubiquitination assays with securin as a substrate 
are also shown. Fig. S4 shows that APC3 RNAi causes a mitotic arrest, 
which can be overridden by adding the Cdk1 inhibitor roscovitine. Fig. S5   
shows the stability of APC/C substrates in APC3 RNAi cells and the loss 
of the cyclin B1 interaction with remaining APC/C
Cdc20 complexes in these 
cells, whereas Cdc20 is still bound to remaining APC/C complexes. Video 1   
shows mitotic progression of a cell in which Cdk1 RNAi was complemented 
by Cdk1*–EYFP expression. Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.200912084/DC1.
We thank Barbara di Fiore and Jon Pines for sharing data before publication. 
This work is funded by a Vidi grant from The Netherlands Organization for 
Fundamental Research (NWO) and by the KWF (Dutch Cancer Society; grants 
NKI 2003-2967, NKI 2007-3789, and NKI 2008-4135).
Submitted: 14 December 2009
Accepted: 28 July 2010
Note added in proof.  Recently, we learned that di Fiore and Pines (2010), 
in a study published in this issue, show that Cks supports APC/C-mediated 
ubiquitination of cyclin A. Their work also reveals that cyclin A binds Cdc20 
and competes with checkpoint proteins. Our combined results support a 
model in which Cks directs recruitment of both mitotic cyclins to the phos-
phorylated APC/C, but complexes between the N terminus of cyclin A and 
Cdc20 evade checkpoint control. This would explain why cyclin A destruction 
starts in prometaphase, when the APC/C is phosphorylated. Recognition of 
the destruction region of cyclin B1 by APC/C
Cdc20 awaits release of the 
spindle checkpoint.
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